Nelson Anita L, Ritchie Julia J
Department of Obstetrics and Gynecology, Harbor-UCLA Medical Center, Torrance, CA.
Los Angeles BioMedical Research Institute, Harbor-UCLA Medical Center, Torrance, CA.
Am J Obstet Gynecol. 2015 Jul;213(1):97.e1-97.e6. doi: 10.1016/j.ajog.2015.04.023. Epub 2015 Apr 29.
The objective of the study was to analyze the behaviors of women that resulted in menstrually related severe anemia (hemoglobin <5 g/dL) from a single public hospital serving indigent women.
This was a retrospective cohort study of all women identified as having been treated at Harbor-UCLA Medical Center for excessive menstruation (International Classification of Diseases, ninth revision, codes 285.9, 6256.2) and hemoglobin values less than 5 g/dL in the 6 years from 2008 to 2013.
Approvals were obtained from the Human Subjects and Research Committees. This search identified 271 women with those 2 diagnoses; 122 were excluded because their severe anemia had nonmenstrual causes. The remaining 149 women had 168 episodes with hemoglobin levels below 5 g/dL attributed to chronic excessive menstrual bleeding. Mean age was 41 years (range, 19-55 years). Mean body mass index was 28.9 kg/m(2) (range, 18-57 kg/m(2)); 58.2% were actively bleeding at presentation, and 90.4% reported chronic excessive blood loss. Two thirds recognized heavy bleeding that had persisted for more than 6 months without seeking help. However, 7.8% described their bleeding as normal, and 40.5% had received at least 1 previous transfusion. Mean nadir hemoglobin was 4.15 g/dL (range, 1.6-4.9 g/dL). Mean corpuscular volume was 62.2 fL (range, 47.7-99.8 fL) and mean corpuscular hemoglobin concentration was 29.2 g/dL (range, 25.7-33.6 g/dL). Nearly a quarter had reactive thrombocytosis, which might have created a hypercoagulable state. Bleeding was ultimately attributed to leiomyoma in 47.9%; cancer was detected in 4.8%. A total of 33.9% were discharged without being offered any therapy to prevent subsequent bleeding; 3.0% declined any medical therapy; 35.1% were lost to follow-up prior to receiving effective therapy; and 26.8% had multiple subsequent transfusions before seeking/receiving definitive treatments.
Even when faced with potentially life-threatening anemia because of chronic, excessive menstrual blood loss, some women are not impressed with the serious nature of their problem. Women will benefit from recognizing the health consequences of chronic excessive blood loss. Chronic excessive blood loss should be treated as both an urgent and potentially recurrent problem; physicians should address this clinical concern proactively.
本研究旨在分析一家为贫困女性服务的公立医院中导致与月经相关的严重贫血(血红蛋白<5g/dL)的女性行为。
这是一项回顾性队列研究,研究对象为2008年至2013年期间在哈伯-加州大学洛杉矶分校医学中心因月经过多(国际疾病分类第九版,编码285.9、6256.2)且血红蛋白值低于5g/dL而接受治疗的所有女性。
获得了人类受试者和研究委员会的批准。此次检索确定了271名有上述两种诊断的女性;122名被排除,因为她们的严重贫血有非月经原因。其余149名女性有168次血红蛋白水平低于5g/dL的发作,归因于慢性月经过多出血。平均年龄为41岁(范围19 - 55岁)。平均体重指数为28.9kg/m²(范围18 - 57kg/m²);58.2%的患者就诊时正在出血,90.4%的患者报告有慢性失血过多。三分之二的人认识到严重出血持续了6个月以上却未寻求帮助。然而,7.8%的人将她们的出血描述为正常,40.5%的人此前至少接受过1次输血。最低血红蛋白平均值为4.15g/dL(范围1.6 - 4.9g/dL)。平均红细胞体积为62.2fL(范围47.7 - 99.8fL),平均红细胞血红蛋白浓度为29.2g/dL(范围25.7 - 33.6g/dL)。近四分之一的人有反应性血小板增多症,这可能导致高凝状态。出血最终归因于平滑肌瘤的占47.9%;检测到癌症的占4.8%。共有33.9%的患者出院时未接受任何预防后续出血的治疗;3.0%的患者拒绝任何药物治疗;35.1%的患者在接受有效治疗前失访;26.8%的患者在寻求/接受确定性治疗前有多次后续输血。
即使面对因慢性月经过多失血导致的潜在危及生命的贫血,一些女性也未意识到自身问题的严重性。女性将从认识慢性失血过多的健康后果中受益。慢性失血过多应被视为一个紧急且可能复发的问题;医生应积极处理这一临床问题。